AventaMed develops novel medical devices which streamline surgery, allowing procedures to move out of the Operating Room and into new sites of service, such as the doctor’s office or clinic.
Solo TTD is a unique all-in-one surgiccal device that offers several advantages to the ENT surgeon, patient and healthcare provider:
The Solo TTD will be transforming the way ear tube surgery is performed. The current care pathway (in treating children) involves a surgical procedure in the operating theatre while the patient is under general anesthesia (“asleep”). Solo TTD enables the healthcare provider to implant tympanostomy tubes in an office / clinic environment with as little as topical anesthesia. This improves patient safety, patient satisfaction, and overall cost to the healthcare system.
AventaMed was crowned Seedcorn’s Overall Winner for the Best Early Stage Company in 2014 and Emerging Medtech Company of the Year, Irish Medical Device Association (IMDA) in 2015The AventaMed team have successfully completed clinical studies and gained ISO 13485 certification, and for the Solo TTD device in Europe. We are now focused on European commercialization and gaining FDA clearance for Solo+ TTD.
Ireland, UK, Portugal, Nordic region, Italy
Tel: +353 (0) 21 492 8980